The CAPTAIN trial series investigated safety and efficacy in this group
Tissues were homogenized in RLT buffer (QIAGEN), a lysis buffer that inactivates RNases and facilitates RNA extraction, using a bead homogenizer for 3 min at maximum speed (Qiagen, TissueLyser II)
However, the phase III clinical trials fell short of the primary endpoint, and the investigation was halted due to its lack of efficacy in improving negative symptoms [76]
Yet, some opine that maternal genetics pose a potential confounding factor if it causes both increased maternal acetaminophen usage (e.g., due to frequent fevers in pregnancy) and offspring neurodevelopmental outcomes
GHK-Cu + TB-500 (Thymosin Beta-4 Fragment) Commonly researched for complementary interaction with: Tissue-maintenance and regenerative pathways Cellular-migration and tissue-remodeling mechanisms Recovery-focused physiological signaling Connective-tissue and extracellular-matrix pathways Physiological-resilience research This combination is commonly investigated in regenerative and recovery-focused research settings